GB0428384D0 - Eicosapentaenoic acid - Google Patents

Eicosapentaenoic acid

Info

Publication number
GB0428384D0
GB0428384D0 GBGB0428384.2A GB0428384A GB0428384D0 GB 0428384 D0 GB0428384 D0 GB 0428384D0 GB 0428384 A GB0428384 A GB 0428384A GB 0428384 D0 GB0428384 D0 GB 0428384D0
Authority
GB
United Kingdom
Prior art keywords
eicosapentaenoic acid
eicosapentaenoic
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0428384.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SLA Pharma AG
Original Assignee
SLA Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SLA Pharma AG filed Critical SLA Pharma AG
Priority to GBGB0428384.2A priority Critical patent/GB0428384D0/en
Publication of GB0428384D0 publication Critical patent/GB0428384D0/en
Priority to PCT/GB2005/005063 priority patent/WO2006067498A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0428384.2A 2004-12-24 2004-12-24 Eicosapentaenoic acid Ceased GB0428384D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0428384.2A GB0428384D0 (en) 2004-12-24 2004-12-24 Eicosapentaenoic acid
PCT/GB2005/005063 WO2006067498A1 (en) 2004-12-24 2005-12-23 Eicosapentaenoic acid for the treatment of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0428384.2A GB0428384D0 (en) 2004-12-24 2004-12-24 Eicosapentaenoic acid

Publications (1)

Publication Number Publication Date
GB0428384D0 true GB0428384D0 (en) 2005-02-02

Family

ID=34130947

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0428384.2A Ceased GB0428384D0 (en) 2004-12-24 2004-12-24 Eicosapentaenoic acid

Country Status (2)

Country Link
GB (1) GB0428384D0 (en)
WO (1) WO2006067498A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
WO2010119319A1 (en) * 2009-03-09 2010-10-21 Pronova Biopharma Norge As Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof
ES2345241B1 (en) 2009-03-16 2011-09-08 Lipopharma Therapeutics USE OF 2-HYDROXIDERIVATES OF POLYINSATURATED FATTY ACIDS AS MEDICINES.
WO2012141575A1 (en) * 2011-04-14 2012-10-18 N.V.Nutricia Combination of epa, dpa and/or dha with a chemotherapeutic agent
US9629820B2 (en) 2012-12-24 2017-04-25 Qualitas Health, Ltd. Eicosapentaenoic acid (EPA) formulations
US10123986B2 (en) 2012-12-24 2018-11-13 Qualitas Health, Ltd. Eicosapentaenoic acid (EPA) formulations
KR20180051735A (en) * 2016-11-08 2018-05-17 차의과학대학교 산학협력단 Composition for prevention and recurrence of intestinal polyposis comprising omega-3 polyunsaturated fatty acid
CN108778284A (en) * 2017-02-09 2018-11-09 S.L.A.制药股份公司 High-purity free fatty eicosapentaenoic acid reduces patients of ulcerative colitis excrement calprotectin levels and prevents clinical recurrence
WO2018150257A1 (en) * 2017-02-14 2018-08-23 S.L.A. Pharma Ag Treatment with highly purified eicosapentaenoic acid as free fatty acid improves inflammation, affects colonic differentiation markers and microbiota in patients with ulcerative colitis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0686377B2 (en) * 1985-09-30 1994-11-02 日清製粉株式会社 Cancer metastasis inhibitor
GB2223943A (en) * 1988-10-21 1990-04-25 Tillotts Pharma Ag Oral disage forms of omega-3 polyunsaturated acids
GB2300807B (en) * 1995-05-15 1999-08-18 Tillotts Pharma Ag Oral dosage forms of omega-3 polynunsaturated acids for the treatment of inflammatory bowel disease
GB0111282D0 (en) * 2001-05-09 2001-06-27 Laxdale Ltd Potentiation of therapeutic effects of fatty acids

Also Published As

Publication number Publication date
WO2006067498A1 (en) 2006-06-29

Similar Documents

Publication Publication Date Title
IL189895A0 (en) Triarylcarboxylic acid derivative
EP1911738A4 (en) Phenoxyalkanoic acid compound
ZA200605354B (en) Prostaglandin nitrooxyderivatives
EP1916234A4 (en) Cyclopropanecarboxylic acid compound
AP2006003810A0 (en) 4-Phenylamino-quinazolin-6-yl-amides
IL181330A0 (en) Thiazolo-naphthyl acids
DE502005007040D1 (en) Laryngoskop
DE502005007456D1 (en) Nanoemulsionen
IL183058A0 (en) Trans-fatty acid free shortening
DE502004004685D1 (en) Giessmaschine
GB0428384D0 (en) Eicosapentaenoic acid
GB0416982D0 (en) Oxidation process
DE502005006813D1 (en) Common-rail-injektor
DE502004004917D1 (en) Multiaxialkomplex
DE502005004945D1 (en) Auto-splice-system
GB0400993D0 (en) Stable gabapentin compositions
AP2006003847A0 (en) Benzhimidazolone carboxylic acid derivatives
GB0512943D0 (en) Indazole-1-acetic acid compounds
GB0517791D0 (en) Pro tab digi-glove
AU2909P (en) DT23 Dianella tasmanica
GB0408246D0 (en) Bite trays
GB0425900D0 (en) Novel pyrrolopyridine-2-carboxylic acid amide
ZA200504665B (en) Artefact
PL114636U1 (en) Shape
PL114637U1 (en) Shape

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)